Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8964312 | Kidney International Reports | 2018 | 10 Pages |
Abstract
This study provides a precise description of kidney pathology in cblC deficiency. Due to major therapeutic implications, we suggest that patients with renal TMA be screened for cblC deficiency regardless of age, particularly when the kidney biopsy provides evidence of long-lasting TMA, including a vacuolated aspect of the glomerular basement membrane and glomerular capillary wall IgM deposition.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Mathilde Lemoine, Arnaud François, Steven Grangé, Marion Rabant, Valérie Châtelet, David Cassiman, Emilie Cornec-Le Gall, Damien Ambrosetti, Georges Deschênes, Jean-François Benoist, Dominique Guerrot,